🏛️ Verified NIH Record • Updated 2026-08-12

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM (NCT06845202)

A Phase 1/2, Randomized, Double-blind, Placebo-controlled 2-part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-4324 in Overweight to Obese Adult Healthy Volunteers and Multiple Dose ALN-4324 in Overweight to Obese Patients With Type 2 Diabetes Mellitus (T2DM)

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic Sponsor: Alnylam Pharmaceuticals

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this study is to: * evaluate the safety and tolerability of single ascending doses of ALN-4324 in healthy volunteers and to characterize the single-dose PK of ALN-4324 * evaluate the efficacy, safety, tolerability, PK, and pharmacodynamics (PD) of multiple doses of ALN-4324 in adult overweight to obese patients with T2DM

Who can join: Review the eligibility criteria below.

Location: Clinical Trial Site — Montclair, California

Age range: 18 Years to 75 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (22 Sites)

  • Clinical Trial Site — Montclair, California
  • Clinical Trial Site — Washington D.C., District of Columbia
  • Clinical Trial Site — Miami, Florida
  • Clinical Trial Site — Marlton, New Jersey
  • Clinical Trial Site — Monroe, North Carolina
  • Clinical Trial Site — Dallas, Texas
  • Clinical Trial Site — Dallas, Texas
  • Clinical Trial Site — Buenos Aires,
  • Clinical Trial Site — Buenos Aires,
  • Clinical Trial Site — Buenos Aires,
  • Clinical Trial Site — San Miguel de Tucumán,
  • Clinical Trial Site — Concord,
  • Clinical Trial Site — Mount Royal,
  • Clinical Trial Site — Vancouver,
  • Clinical Trial Site — Santiago,
  • Clinical Trial Site — Santiago,
  • Clinical Trial Site — Santiago,
  • Clinical Trial Site — Essen,
  • Clinical Trial Site — Gdansk,
  • Clinical Trial Site — Tarnów,
  • Clinical Trial Site — Warsaw,
  • Clinical Trial Site — Wroclaw,

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗